Evidence map›Paper›PMID 27308733›Full record

ArticleAutophagy2016

Simultaneous inhibition of the ubiquitin-proteasome system and autophagy enhances apoptosis induced by ER stress aggravators in human pancreatic cancer cells.

Xu Li, Feng Zhu, Jianxin Jiang, Chengyi Sun, Qing Zhong, Ming Shen, Xin Wang, Rui Tian, Chengjian Shi, Meng Xu and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Autophagy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 92 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Pharmaceutics · 2022
    Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Xu Lia Department of Biliary-Pancreatic Surgery , Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan , China.
Feng Zhua Department of Biliary-Pancreatic Surgery , Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan , China.
Jianxin Jiangb Department of Hepatic-Biliary-Pancreatic Surgery , Hubei Cancer Hospital , Wuhan , China.
Chengyi Sunc Department of Biliary-Hepatic Surgery , Affiliated Hospital of Guiyang Medical College , Guizhou , China.
Qing Zhongd Center for Autophagy Research, Department of Internal Medicine, University of Texas Southwestern Medical Center , Dallas , TX , USA.
Ming Shena Department of Biliary-Pancreatic Surgery , Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan , China.
Xin Wanga Department of Biliary-Pancreatic Surgery , Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan , China.
Rui Tiana Department of Biliary-Pancreatic Surgery , Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan , China.
Chengjian Shia Department of Biliary-Pancreatic Surgery , Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan , China.
Meng Xua Department of Biliary-Pancreatic Surgery , Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan , China.
Feng Penga Department of Biliary-Pancreatic Surgery , Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan , China.
Xingjun Guoa Department of Biliary-Pancreatic Surgery , Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan , China.
Jun Hue Department of Colon Cancer , Tianjin Medical University Cancer Institute and Hospital , Tianjin , China.
Dawei Yef Department of Oncology , Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan , China.
Min Wanga Department of Biliary-Pancreatic Surgery , Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan , China.
Renyi Qina Department of Biliary-Pancreatic Surgery , Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan , China.
Tongji Hospital · CNHuazhong University of Science and Technology · CNHubei Cancer Hospital · CNThe University of Texas Southwestern Medical Center · USTianjin Medical University Cancer Institute and Hospital · CN

Funding

Biochemical Dissection and Reconstitution of Autophagic Membrane FusionR01GM116908 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI ZHONG, QING · 2015 to 2018
$1.3M
NIGMS NIH HHS R01 GM116908
6 · The paper itself

Abstract

In contrast to normal tissue, cancer cells display profound alterations in protein synthesis and degradation. Therefore, proteins that regulate endoplasmic reticulum (ER) homeostasis are being increasingly recognized as potential therapeutic targets. The ubiquitin-proteasome system and autophagy are crucially important for proteostasis in cells. However, interactions between autophagy, the proteasome, and ER stress pathways in cancer remain largely undefined. This study demonstrated that withaferin-A (WA), the biologically active withanolide extracted from Withania somnifera, significantly increased autophagosomes, but blocked the degradation of autophagic cargo by inhibiting SNARE-mediated fusion of autophagosomes and lysosomes in human pancreatic cancer (PC) cells. WA specifically induced proteasome inhibition and promoted the accumulation of ubiquitinated proteins, which resulted in ER stress-mediated apoptosis. Meanwhile, the impaired autophagy at early stage induced by WA was likely activated in response to ER stress. Importantly, combining WA with a series of ER stress aggravators enhanced apoptosis synergistically. WA was well tolerated in mice, and displayed synergism with ER stress aggravators to inhibit tumor growth in PC xenografts. Taken together, these findings indicate that simultaneous suppression of 2 key intracellular protein degradation systems rendered PC cells vulnerable to ER stress, which may represent an avenue for new therapeutic combinations for this disease.

Indexed as

AnimalsAntineoplastic AgentsApoptosisAutophagosomesAutophagyCell DeathCell Line, TumorCell SurvivalEndoplasmic Reticulum StressFemaleHomeostasisHumansLysosomesMaleMiceMice, Inbred BALB CAntineoplastic AgentsPlant ExtractsProteasome Endopeptidase ComplexProteasome InhibitorsSequestosome-1 ProteinSQSTM1 protein, humanUbiquitinwithaferin AWithanolidesautophagyER stressproteasomeSNAREswithaferin A

Identifiers

PMID27308733
PMCPMC5082778
OpenAlexW2420981549

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.